data_6x7i_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6x7i _Structure_validation_residue.Date_analyzed 2020-06-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -78.78 146.21 33.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.71 147.44 52.5 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -129.7 146.42 51.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.91 147.85 51.71 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -90.92 109.58 20.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.23 -37.79 88.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -63.49 -38.01 89.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.468 ' H3 ' ' CZ ' ' A' ' 209' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.18 -38.73 91.45 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -124.75 152.29 44.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.468 ' CZ ' ' H3 ' ' A' ' 206' ' ' GLY . 38.6 mmt180 -129.6 144.77 51.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -141.85 127.09 18.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -155.77 88.16 1.11 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.98 142.25 48.75 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -84.21 -7.21 59.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -155.13 163.79 39.74 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -125.46 148.52 48.81 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.97 140.87 52.57 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -130.01 147.64 51.78 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -89.64 99.69 12.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.17 15.52 21.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -64.31 -42.73 96.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.96 129.79 47.36 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -133.35 148.01 51.84 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -155.76 163.03 40.37 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.77 121.84 46.14 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -102.61 5.83 39.41 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -126.81 130.77 50.91 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -86.79 -7.2 58.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -153.2 152.69 31.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.42 113.82 4.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -140.79 151.02 44.08 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.69 145.72 51.08 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -142.23 109.37 5.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.37 -3.66 39.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -64.64 -45.16 88.01 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.046 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -87.5 121.48 29.99 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.83 159.82 35.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -131.83 147.78 52.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -124.59 107.89 11.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -131.07 123.93 29.74 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -135.02 143.32 46.71 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -70.62 -28.76 65.08 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.07 126.85 43.73 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -138.37 148.69 44.8 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -123.29 125.36 44.9 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -163.62 163.71 24.33 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -85.28 109.46 18.37 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.74 -37.31 87.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.625 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -63.04 -36.47 83.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -145.74 136.91 24.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -97.53 137.12 36.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -153.0 154.42 34.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -63.81 -50.11 70.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -177.91 179.22 0.88 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -73.37 135.73 44.31 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -63.38 -41.19 98.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.56 149.81 52.38 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.98 -41.43 95.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -89.0 116.66 27.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -163.73 148.41 10.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -76.15 127.27 32.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -132.98 147.18 52.28 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -72.5 -15.72 61.79 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -96.57 122.5 39.56 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.14 145.12 48.98 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -133.21 133.77 43.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.55 145.74 47.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -104.14 111.07 23.51 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -133.77 145.76 50.1 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -84.11 -10.21 57.98 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 216' ' ' THR . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 219' ' ' THR . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 219' ' ' THR . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 219' ' ' THR . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 216' ' ' THR . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 219' ' ' THR . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 223' ' ' VAL . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 219' ' ' THR . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 220' ' ' VAL . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 223' ' ' VAL . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 216' ' ' THR . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 219' ' ' THR . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 220' ' ' VAL . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 224' ' ' VAL . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 220' ' ' VAL . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 216' ' ' THR . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 219' ' ' THR . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 219' ' ' THR . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 216' ' ' THR . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 219' ' ' THR . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -78.78 146.21 33.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.71 147.44 52.5 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -129.7 146.42 51.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.91 147.85 51.71 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -90.92 109.58 20.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.23 -37.79 88.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -63.49 -38.01 89.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 216' ' ' THR . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 219' ' ' THR . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.18 -38.73 91.45 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -124.75 152.29 44.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -129.6 144.77 51.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -141.85 127.09 18.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -155.77 88.16 1.11 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.98 142.25 48.75 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -84.21 -7.21 59.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 219' ' ' THR . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -155.13 163.79 39.74 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -125.46 148.52 48.81 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.97 140.87 52.57 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -130.01 147.64 51.78 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -89.64 99.69 12.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.17 15.52 21.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -64.31 -42.73 96.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 219' ' ' THR . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.96 129.79 47.36 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -133.35 148.01 51.84 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -155.76 163.03 40.37 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.77 121.84 46.14 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -102.61 5.83 39.41 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -126.81 130.77 50.91 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -86.79 -7.2 58.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 216' ' ' THR . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 219' ' ' THR . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -153.2 152.69 31.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.42 113.82 4.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -140.79 151.02 44.08 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.69 145.72 51.08 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -142.23 109.37 5.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.37 -3.66 39.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -64.64 -45.16 88.01 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 223' ' ' VAL . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 219' ' ' THR . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.046 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -87.5 121.48 29.99 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.83 159.82 35.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -131.83 147.78 52.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -124.59 107.89 11.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -131.07 123.93 29.74 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -135.02 143.32 46.71 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -70.62 -28.76 65.08 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 220' ' ' VAL . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 223' ' ' VAL . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 216' ' ' THR . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 219' ' ' THR . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.07 126.85 43.73 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -138.37 148.69 44.8 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -123.29 125.36 44.9 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -163.62 163.71 24.33 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -85.28 109.46 18.37 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.74 -37.31 87.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.625 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -63.04 -36.47 83.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 220' ' ' VAL . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 224' ' ' VAL . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 220' ' ' VAL . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -145.74 136.91 24.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -97.53 137.12 36.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -153.0 154.42 34.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -63.81 -50.11 70.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -177.91 179.22 0.88 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -73.37 135.73 44.31 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -63.38 -41.19 98.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 216' ' ' THR . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 219' ' ' THR . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.56 149.81 52.38 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.98 -41.43 95.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -89.0 116.66 27.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -163.73 148.41 10.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -76.15 127.27 32.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -132.98 147.18 52.28 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -72.5 -15.72 61.79 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 219' ' ' THR . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -96.57 122.5 39.56 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.14 145.12 48.98 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -133.21 133.77 43.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.55 145.74 47.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -104.14 111.07 23.51 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -133.77 145.76 50.1 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -84.11 -10.21 57.98 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 216' ' ' THR . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 219' ' ' THR . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 . . . . . 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 216' ' ' THR . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 219' ' ' THR . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 219' ' ' THR . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 219' ' ' THR . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 216' ' ' THR . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 219' ' ' THR . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 . . . . . 0 CA--C 1.507 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 223' ' ' VAL . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 219' ' ' THR . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 . . . . . 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 220' ' ' VAL . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 223' ' ' VAL . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 216' ' ' THR . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 219' ' ' THR . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 220' ' ' VAL . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 224' ' ' VAL . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 220' ' ' VAL . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 . . . . . 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 216' ' ' THR . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 219' ' ' THR . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 219' ' ' THR . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 . . . . . 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 216' ' ' THR . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 219' ' ' THR . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.973 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -78.78 146.21 33.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.71 147.44 52.5 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -129.7 146.42 51.48 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -129.91 147.85 51.71 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -90.92 109.58 20.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.23 -37.79 88.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -63.49 -38.01 89.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -62.87 -42.67 99.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.64 -43.68 88.73 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.1 m -63.53 -45.74 89.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.37 99.7 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 65.5 ttp -64.33 -42.45 96.27 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.56 -44.31 94.5 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 216' ' ' THR . 58.9 t -62.18 -44.92 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.67 98.53 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.68 -41.03 99.15 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 219' ' ' THR . 59.5 t -63.02 -43.09 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.2 t -62.08 -46.28 96.82 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.36 -39.73 95.34 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 121.853 -0.529 . . . . 0.0 110.018 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.17 -39.88 78.47 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.52 -40.74 99.5 Favored Glycine 0 C--N 1.35 1.349 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.7 m -65.28 -42.44 93.17 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.81 -45.5 93.59 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -66.88 -38.49 86.4 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 74.3 m -64.26 -42.18 96.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -64.42 -43.92 92.87 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt . . . . . 0 C--O 1.263 1.79 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.648 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.18 -38.73 91.45 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -124.75 152.29 44.0 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -129.6 144.77 51.42 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -141.85 127.09 18.61 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -155.77 88.16 1.11 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -132.98 142.25 48.75 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -84.21 -7.21 59.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -68.61 -29.49 68.02 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.4 tp -69.09 -41.51 77.39 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.2 m -64.51 -44.4 91.03 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.34 -41.93 99.73 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.5 tpp -64.83 -41.63 95.58 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.5 m -63.16 -44.52 95.22 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.23 -45.06 99.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.29 98.66 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.93 99.33 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 219' ' ' THR . 59.4 t -62.79 -43.09 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.09 -46.47 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.08 -39.55 95.05 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.921 -0.487 . . . . 0.0 109.928 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.4 -39.81 81.55 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.41 -41.43 99.76 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.7 t -64.45 -45.14 88.75 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.8 tp -60.9 -46.13 91.86 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -66.52 -38.83 88.05 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 43.9 t -62.85 -45.13 94.01 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -65.95 -40.14 91.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 tttm . . . . . 0 C--O 1.262 1.752 0 CA-C-O 117.934 -1.031 . . . . 0.0 108.479 179.596 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.112 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 15.8 pm0 -155.13 163.79 39.74 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -125.46 148.52 48.81 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.97 140.87 52.57 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -130.01 147.64 51.78 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -89.64 99.69 12.65 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -111.17 15.52 21.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -64.31 -42.73 96.19 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -63.85 -38.77 92.34 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.8 tp -67.32 -41.78 84.74 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 94.2 m -63.48 -44.54 94.1 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.07 -42.7 99.74 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 98.0 mtp -65.4 -39.74 92.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -64.08 -44.85 91.1 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.77 -44.89 99.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.53 98.36 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.77 99.58 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 219' ' ' THR . 63.5 t -64.01 -43.39 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.13 -47.38 93.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.678 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 7.3 mp -64.65 -38.68 91.84 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.875 -0.515 . . . . 0.0 109.708 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.4 tt -66.08 -42.95 88.66 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.87 -40.19 98.96 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 71.9 m -64.46 -45.93 85.28 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.13 -40.42 97.54 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -61.67 -46.61 89.01 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.5 m -62.86 -41.75 99.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -64.86 -40.25 94.85 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.0 tttt . . . . . 0 C--O 1.263 1.805 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.993 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.96 129.79 47.36 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -133.35 148.01 51.84 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.4 ' NE ' HD21 ' A' ' 211' ' ' ASN . 41.1 ptt180 -155.76 163.03 40.37 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.77 121.84 46.14 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.4 HD21 ' NE ' ' A' ' 209' ' ' ARG . 34.1 m120 -102.61 5.83 39.41 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 42.3 mmt180 -126.81 130.77 50.91 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -86.79 -7.2 58.47 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -67.65 -33.57 75.21 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.19 -38.82 75.44 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.3 m -65.29 -44.89 86.53 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.8 -41.72 99.81 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.4 ttp -63.73 -42.81 97.85 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.4 m -63.33 -44.48 94.76 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 216' ' ' THR . 61.9 t -62.25 -45.24 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.26 -41.47 98.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.74 99.25 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 219' ' ' THR . 61.2 t -63.69 -43.68 98.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.42 -47.14 94.41 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.42 -38.94 93.09 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 121.918 -0.489 . . . . 0.0 109.696 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -66.31 -42.07 88.78 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.94 98.23 Favored Glycine 0 C--N 1.352 1.43 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -62.92 -44.67 95.45 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.87 -41.22 97.59 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -67.75 -40.1 84.13 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 44.3 t -63.4 -44.55 94.34 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.52 -44.74 93.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 61.6 tttt . . . . . 0 C--O 1.263 1.802 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.623 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -153.2 152.69 31.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.42 113.82 4.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -140.79 151.02 44.08 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -128.69 145.72 51.08 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -142.23 109.37 5.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -97.37 -3.66 39.89 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -64.64 -45.16 88.01 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -65.27 -37.29 86.74 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.53 -39.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 95.3 m -63.81 -42.6 97.65 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.65 -41.4 99.58 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.2 -40.46 94.19 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 223' ' ' VAL . 97.3 m -64.64 -43.9 92.18 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.7 t -62.18 -45.24 99.2 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.52 -41.66 99.0 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.23 99.07 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 219' ' ' THR . 57.4 t -63.09 -43.02 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.3 t -62.01 -46.6 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.643 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.35 -39.75 95.38 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.811 -0.556 . . . . 0.0 110.055 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.29 -40.12 81.86 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.75 -40.63 99.44 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.32 -42.68 92.74 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.32 -44.77 96.64 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.43 -37.89 86.19 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -64.51 -41.08 96.64 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -65.36 -38.72 90.92 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? . . . . . 0 C--O 1.263 1.777 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.734 -179.561 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.046 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -87.5 121.48 29.99 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.83 159.82 35.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -131.83 147.78 52.51 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -124.59 107.89 11.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -131.07 123.93 29.74 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -135.02 143.32 46.71 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -70.62 -28.76 65.08 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -66.01 -35.73 81.35 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.5 tp -69.11 -41.97 76.7 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 220' ' ' VAL . 95.1 m -63.73 -45.24 90.83 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.62 -41.67 99.78 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 28.1 ttt -64.29 -42.2 96.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.516 ' O ' HG23 ' A' ' 223' ' ' VAL . 94.9 m -63.53 -44.51 94.03 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 216' ' ' THR . 60.7 t -62.36 -45.18 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.41 98.57 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.45 -40.86 99.28 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 219' ' ' THR . 61.4 t -63.85 -43.57 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.24 -47.37 93.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.63 -38.86 92.71 Favored 'General case' 0 CA--C 1.506 -0.732 0 O-C-N 121.898 -0.501 . . . . 0.0 109.659 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.44 -42.66 92.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.4 -39.72 98.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.3 t -63.16 -43.71 97.51 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -68.27 -37.91 81.18 Favored 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.32 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.8 m -63.87 -42.57 97.48 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -66.53 -40.04 88.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 59.6 tttt . . . . . 0 C--O 1.263 1.768 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.597 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.979 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -127.07 126.85 43.73 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -138.37 148.69 44.8 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -123.29 125.36 44.9 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -163.62 163.71 24.33 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.743 -1.576 . . . . 0.0 106.743 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -85.28 109.46 18.37 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.74 -37.31 87.16 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.625 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -63.04 -36.47 83.68 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -63.04 -41.03 99.4 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.6 mt -66.62 -39.82 88.51 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 220' ' ' VAL . 96.2 m -63.93 -46.15 86.05 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.66 99.84 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 66.1 ttp -63.63 -43.03 98.03 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 94.7 m -63.81 -43.98 94.63 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 224' ' ' VAL . 59.2 t -61.84 -46.31 96.79 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.06 95.99 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 121.726 -0.609 . . . . 0.0 109.53 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.77 -42.96 99.6 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.98 -31.44 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 CA-C-N 118.405 1.103 . . . . 0.0 109.682 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 220' ' ' VAL . 55.7 t -64.48 -47.43 89.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 86.6 mt -64.72 -38.85 92.38 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.73 -43.29 93.87 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.49 -39.39 97.76 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 74.1 m -64.05 -41.87 97.22 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 82.8 mt -61.62 -41.32 97.32 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.76 -37.75 79.6 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.6 m -63.74 -42.72 97.82 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.63 -40.07 88.56 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.8 tttm . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.877 -1.058 . . . . 0.0 108.449 179.664 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -145.74 136.91 24.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -97.53 137.12 36.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -153.0 154.42 34.92 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -63.81 -50.11 70.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -177.91 179.22 0.88 Allowed 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -73.37 135.73 44.31 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -63.38 -41.19 98.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -62.96 -37.95 89.13 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.84 -42.26 81.68 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 220' ' ' VAL . 97.7 m -63.57 -44.15 94.94 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -61.91 -43.18 99.55 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 62.9 mtt -65.69 -39.45 91.3 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 121.983 -0.716 . . . . 0.0 109.109 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.1 m -63.87 -44.51 92.86 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 216' ' ' THR . 63.3 t -62.52 -45.1 99.6 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.27 -41.29 98.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.24 98.99 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 219' ' ' THR . 60.7 t -63.01 -43.68 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 66.5 t -62.23 -46.21 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 60.2 tp -62.02 -42.0 98.69 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.4 mt -67.39 -39.88 85.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.33 -41.37 99.75 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 43.8 t -64.34 -44.11 92.52 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.11 -45.24 95.52 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.25 -38.87 88.89 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.9 m -64.35 -41.84 96.54 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -63.33 -45.3 91.91 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 58.9 tttt . . . . . 0 C--O 1.263 1.788 0 CA-C-O 117.874 -1.06 . . . . 0.0 108.435 179.661 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -131.56 149.81 52.38 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -64.98 -41.43 95.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.3 tpp85 -89.0 116.66 27.46 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -163.73 148.41 10.61 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -76.15 127.27 32.59 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 85.2 mtt85 -132.98 147.18 52.28 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -72.5 -15.72 61.79 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.65 -36.84 84.85 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.3 mt -68.42 -38.74 81.52 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.5 m -64.69 -43.51 93.26 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.0 -42.74 99.75 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 38.6 mmt -65.93 -39.39 90.48 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.8 m -63.92 -44.53 92.64 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 216' ' ' THR . 62.4 t -62.56 -44.97 99.84 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.35 -41.4 98.56 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.69 -41.09 99.12 Favored Glycine 0 C--N 1.351 1.362 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 219' ' ' THR . 61.7 t -64.05 -43.91 97.64 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 64.9 t -62.4 -47.03 94.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 59.4 tp -62.88 -40.75 98.49 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.43 -42.55 92.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.0 -40.05 98.38 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 42.6 t -62.86 -45.02 94.52 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.64 -40.75 96.01 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.53 -40.06 88.94 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 42.5 t -63.99 -43.69 94.93 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.0 -39.02 92.85 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 89.6 mttt . . . . . 0 C--O 1.262 1.757 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.806 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.0 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -96.57 122.5 39.56 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.14 145.12 48.98 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -133.21 133.77 43.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.55 145.74 47.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -104.14 111.07 23.51 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -133.77 145.76 50.1 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -84.11 -10.21 57.98 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -68.83 -31.06 69.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.5 mt -70.17 -38.81 75.49 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 220' ' ' VAL . 93.4 m -65.22 -44.63 87.67 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -62.72 -41.59 99.81 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -63.66 -42.98 98.02 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 223' ' ' VAL . 95.2 m -63.1 -44.27 96.17 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 216' ' ' THR . 61.6 t -62.13 -45.26 99.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.44 -41.24 98.58 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.48 -41.21 99.34 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 219' ' ' THR . 60.0 t -63.07 -43.54 99.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.24 -46.06 97.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.6 tt -62.82 -41.8 99.46 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.917 -0.489 . . . . 0.0 109.847 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.0 -40.02 83.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -62.59 -40.94 99.77 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 73.4 m -65.46 -42.43 92.32 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.96 -45.19 94.74 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -66.29 -39.11 89.14 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 73.3 m -64.54 -41.72 96.16 Favored 'General case' 0 CA--C 1.504 -0.799 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 ttt85 -63.62 -44.7 93.16 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.4 tttt . . . . . 0 C--O 1.262 1.746 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.618 . . . . . . . . 0 0 . 1 stop_ save_